These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9448981)

  • 21. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS.
    Richards G; Levy H; Laterre PF; Feldman C; Woodward B; Bates BM; Qualy RL
    J Intensive Care Med; 2011; 26(1):34-40. PubMed ID: 21341394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT).
    Wiersinga WJ; Bonten MJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; Degener JE; van de Garde EMW; Verheij TJ; Sachs APE; Prins JM
    Neth J Med; 2018 Jan; 76(1):4-13. PubMed ID: 29380739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial therapy for community-acquired pneumonia in adults.
    da Cunha CA; Sader HS; Nicodemo AC;
    Braz J Infect Dis; 2002 Apr; 6(2):82-7. PubMed ID: 11980608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
    Oosterheert JJ; Bonten MJ; Hak E; Schneider MM; Hoepelman IM
    J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of community-acquired pneumonia: a review and update.
    Brar NK; Niederman MS
    Ther Adv Respir Dis; 2011 Feb; 5(1):61-78. PubMed ID: 20935033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the Netherlands.
    Huijts SM; van Werkhoven CH; Boersma WG; Buijs J; Buunk G; Compaijen CJ; van Elde LJ; Gisolf JE; van der Kam R; Kluytmans JA; Kuipers BA; Mager JJ; Oppedijk B; Palmen F; Prins JM; van Reemst B; Silbermann MH; van Tiel FH; van der Wall E; van der Werf TS; Bonten MJ
    Neth J Med; 2013 Dec; 71(10):502-7. PubMed ID: 24394734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current antimicrobial management of community-acquired pneumonia in HIV-infected children.
    Nuttall JJC
    Expert Opin Pharmacother; 2019 Apr; 20(5):595-608. PubMed ID: 30664362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community-acquired pneumonia with risk for drug-resistant pathogens.
    Fleming V; Buck B; Nix N; Kumar P; Southwood R
    South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community-acquired pneumonia.
    Musher DM; Thorner AR
    N Engl J Med; 2014 Oct; 371(17):1619-28. PubMed ID: 25337751
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia.
    Hoogewerf M; Oosterheert JJ; Hak E; Hoepelman IM; Bonten MJ
    Clin Microbiol Infect; 2006 Nov; 12(11):1097-104. PubMed ID: 17002609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Etiology and outcome of community-acquired pneumonia in relation to age and severity in hospitalized adult patients].
    Takayanagi N; Hara K; Tokunaga D; Takaku Y; Minagawa S; Tsuchiya Y; Hijikata N; Yamaji T; Saito H; Ubukata M; Kurashima K; Yanagisawa T; Sugita Y
    Nihon Kokyuki Gakkai Zasshi; 2006 Dec; 44(12):906-15. PubMed ID: 17233386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Update on the role of levofloxacin in the management of acute community-acquired pneumonia].
    Bru JP
    Presse Med; 2002 Jun; 31(21 Pt 2):S19-22. PubMed ID: 12148386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-acquired pneumonia in adults: initial antibiotic therapy.
    King DE; Pippin HJ
    Am Fam Physician; 1997 Aug; 56(2):544-50. PubMed ID: 9262534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community-acquired pneumonia.
    Ong KC; Eng P
    Singapore Med J; 1995 Oct; 36(5):539-44. PubMed ID: 8882544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society.
    Mandell LA; Marrie TJ; Grossman RF; Chow AW; Hyland RH; ;
    Can Respir J; 2000; 7(5):371-82. PubMed ID: 11058205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial Therapy for Pneumonia in the Emergency Department: The Impact of Clinical Pharmacists on Appropriateness.
    Faine BA; Mohr N; Dietrich J; Meadow L; Harland KK; Chrischilles E
    West J Emerg Med; 2017 Aug; 18(5):856-863. PubMed ID: 28874937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe community-acquired pneumonia: approach to therapy.
    Pineda L; El Solh AA
    Expert Opin Pharmacother; 2007 Apr; 8(5):593-606. PubMed ID: 17376015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of an algorithm for switching from IV to PO therapy in clinical practice in patients with community-acquired pneumonia.
    van der Eerden MM; de Graaff CS; Vlaspolder F; Bronsveld W; Jansen HM; Boersma WG
    Clin Ther; 2004 Feb; 26(2):294-303. PubMed ID: 15038952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community-acquired pneumonia. Tailoring management of adult patients according to risk category.
    Rubins JB; Janoff EN
    Postgrad Med; 1997 Dec; 102(6):45-7, 52, 55-62. PubMed ID: 9406562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of worldwide experience with sparfloxacin in the treatment of community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis.
    Finch RG
    Int J Antimicrob Agents; 1999 Jun; 12(1):5-17. PubMed ID: 10389642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.